Literature DB >> 27637120

Diagnosis and Treatment of Atrial Fibrillation.

Cecilia Gutierrez1, Daniel G Blanchard1.   

Abstract

Atrial fibrillation is a supraventricular arrhythmia that adversely affects cardiac function and increases the risk of stroke. It is the most common arrhythmia and a major source of morbidity and mortality; its prevalence increases with age. Pulse rate is sensitive, but not specific, for diagnosis, and suspected atrial fibrillation should be confirmed with 12-lead electrocardiography. Because normal electrocardiographic findings do not rule out atrial fibrillation, home monitoring is recommended if there is clinical suspicion of arrhythmia despite normal test results. Treatment is based on decisions made regarding when to convert to normal sinus rhythm vs. when to treat with rate control, and, in either case, how to best reduce the risk of stroke. For most patients, rate control is preferred to rhythm control. Ablation therapy is used to destroy abnormal foci responsible for atrial fibrillation. Anticoagulation reduces the risk of stroke while increasing the risk of bleeding. The CHA2DS2-VASc scoring system assesses the risk of stroke, with a score of 2 or greater indicating a need for anticoagulation. The HAS-BLED score estimates the risk of bleeding. Scores of 3 or greater indicate high risk. Warfarin, dabigatran, factor Xa inhibitors (e.g., rivaroxaban, apixaban, edoxaban), and aspirin are options for stroke prevention. Selection of therapy should be individualized based on risks and potential benefits, cost, and patient preference. Left atrial appendage obliteration is an option for reducing stroke risk. Two implantable devices used to occlude the appendage, the Watchman and the Amplatzer Cardiac Plug, appear to be as effective as warfarin in preventing stroke, but they are invasive. Another percutaneous approach to occlusion, wherein the left atrium is closed off using the Lariat, is also available, but data on its long-term effectiveness and safety are still limited. Surgical treatments for atrial fibrillation are reserved for patients who are undergoing cardiac surgery for other reasons.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27637120

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  21 in total

1.  Detection of atrial fibrillation during pulpal blood flow assessment using Doppler ultrasound: a case report.

Authors:  Chan-Hyun Lee; Euiseong Kim; Dohyun Kim
Journal:  Dentomaxillofac Radiol       Date:  2018-04-13       Impact factor: 2.419

2.  Swallowing-induced supraventricular arrhythmia: A different perspective to mechanism.

Authors:  S Ozturk; E Yetkin
Journal:  J Postgrad Med       Date:  2021 Apr-Jun       Impact factor: 1.476

Review 3.  Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines.

Authors:  William F McIntyre; Jeff Healey
Journal:  J Atr Fibrillation       Date:  2017-04-30

4.  Value of echocardiography in evaluating efficacy of radiofrequency catheter ablation in patients with atrial fibrillation.

Authors:  Ying Li; Bing Han; Jinfang Li; Fei Ge; Lianwei Yang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 5.  Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review.

Authors:  Jamshed Dalal; Fali Poncha; Sandeep Bansal; Arvind Das; Praveen Gupta; Debasis Ghosh; Anshu Rohatgi; Murugesh S Hiremath; Kartikeya Bhargava; Arun Gopi; Mithun Mali
Journal:  Cureus       Date:  2022-05-18

6.  Atrial Fibrillation in Scrub Typhus: A Series of Four Cases.

Authors:  Harshit Gupta; Ashwin Parchani; Arnab Choudhury; Jithesh G; Monika Pathania; Mukesh Bairwa
Journal:  Cureus       Date:  2022-05-25

7.  Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis.

Authors:  Boon-Hao Suah; Zhi-Yan Lee; Yao Hao Teo; Yao Neng Teo; Nicholas L X Syn; Rodney Y H Soh; Leonard L L Yeo; Benjamin Y Q Tan; Jamie Sin-Ying Ho; Tony Y W Li; Chi-Hang Lee; Mark Y Chan; Tiong-Cheng Yeo; Raymond C C Wong; Ping Chai; Ching-Hui Sia
Journal:  Am J Cardiovasc Drugs       Date:  2022-03-16       Impact factor: 3.283

8.  The impact of post-operative atrial fibrillation on outcomes in coronary artery bypass graft and combined procedures.

Authors:  Yau-Lam Alex Chau; Ji Won Yoo; Ho Chuen Yuen; Khalid Bin Waleed; Dong Chang; Tong Liu; Fang Zhou Liu; Gary Tse; Sharen Lee; Ka Hou Christien Li
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

Review 9.  Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis.

Authors:  William F McIntyre; Maria E Vadakken; Anand S Rai; Terry Thach; Wajahat Syed; Kevin J Um; Omar Ibrahim; Shreyash Dalmia; Akash Bhatnagar; Pablo A Mendoza; Alexander P Benz; Shrikant I Bangdiwala; Jessica Spence; Graham R McClure; Jessica T Huynh; Tianyi Zhang; Toru Inami; David Conen; P J Devereaux; Richard P Whitlock; Jeff S Healey; Emilie P Belley-Côté
Journal:  Can J Anaesth       Date:  2021-02-23       Impact factor: 6.713

10.  Effect of variability of central venous pressure values to prevent atrial fibrillation after coronary bypass grafting.

Authors:  Seyed Hossein Hamidi; Ghasem Faghanzadeh-Ganji; Ali Baghaeian; Ali Bijani; Roghaieh Pourkia
Journal:  Caspian J Intern Med       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.